Astellas Pharma: Difference between revisions
CSV import |
CSV import |
||
| Line 33: | Line 33: | ||
{{pharmacology-stub}} | {{pharmacology-stub}} | ||
<gallery> | |||
File:Astellas_Pharma_logo.svg|Astellas Pharma Logo | |||
File:AstellasPharmaCanada.jpg|Astellas Pharma Canada Office | |||
File:2-arachidonoylglycerol_3D_BS.png|3D Structure of 2-arachidonoylglycerol | |||
</gallery> | |||
Latest revision as of 00:47, 18 February 2025
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, headquartered in Tokyo, Japan. The company was established on April 1, 2005, through the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. Astellas is involved in the research, development, manufacture, import, and export of pharmaceuticals.
History[edit]
The history of Astellas Pharma Inc. is marked by the merger of two leading Japanese pharmaceutical companies, Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. The merger was aimed at creating a more robust entity capable of competing on the global market.
Business Operations[edit]
Astellas Pharma Inc. operates in over 70 countries worldwide. The company's primary areas of focus include oncology, immunology, urology, and neuroscience. Astellas is also involved in the development of pharmaceuticals for infectious diseases and cardiovascular diseases.
Research and Development[edit]
Astellas Pharma Inc. has a strong commitment to research and development. The company's R&D efforts are focused on creating innovative drugs that can contribute to the health of patients around the world. Astellas has research facilities in Japan, North America, and Europe.
Products[edit]
Some of the key products of Astellas Pharma Inc. include Prograf, a drug used to prevent organ rejection in transplant patients, and Xtandi, a drug used to treat prostate cancer. The company also manufactures Vesicare, a drug used to treat overactive bladder.
Corporate Social Responsibility[edit]
Astellas Pharma Inc. is committed to fulfilling its corporate social responsibility through various initiatives. These include efforts to improve access to medicines, promote health education, and contribute to the sustainable development of society.
See Also[edit]
References[edit]
<references />
External Links[edit]
-
Astellas Pharma Logo
-
Astellas Pharma Canada Office -
3D Structure of 2-arachidonoylglycerol
